NextPharma has successfully completed a PMDA inspection resulting in continued accreditation at its Braine-l’Alleud site, near Brussels in Belgium, a specialist facility for aseptic production and packaging, including the manufacture of cytotoxic products. The Braine-l’Alleud site had received accreditation by the Japanese regulatory authorities based on previous submissions. This most recent accreditation follows a new product launch requiring a preapproval inspection of the cytotoxic manuf...